| Register
| Log out
Submit An Article

ASX:RHT

Latest Articles

  • Resonance soars on $14m contract win with big pharma

    Resonance soars on $14m contract win with big pharma

    The share price of healthcare technology and services business Resonance Health (ASX: RHT) surged by more than 50 per cent on Tuesday after the company nailed down a two-year clinical trial agreement with Indian multinational pharmaceutical titan, Sun Pharmaceuticals. The $13.775 million deal will see Resonance act as the local Australian sponsor and provide clinical

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.